These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 49470)

  • 1. New variant of phenylketonuria with progressive neurological illness unresponsive to phenylalanine restriction.
    Smith I; Clayton BE; Wolff OH
    Lancet; 1975 May; 1(7916):1108-11. PubMed ID: 49470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of phenylalanine disappearance after intravenous load in phenylketonuria and its genetic variants.
    Rey F; Blandin-Savoja F; Rey J
    Pediatr Res; 1979 Jan; 13(1):21-5. PubMed ID: 431997
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperphenylalaninemia due to a deficiency of biopterin. A variant form of phenylketonuria.
    Kaufman S; Berlow S; Summer GK; Milstien S; Schulman JD; Orloff S; Spielberg S; Pueschel S
    N Engl J Med; 1978 Sep; 299(13):673-9. PubMed ID: 683251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperphenylalaninaemia with normal phenylalanine-hydroxylase activity and a deficiency of tetrahydrobiopterin and dihydropteridine reductase].
    Rey F; Harpey JP; Leeming RJ; Blair JA; Aicardi J; Rey J
    Arch Fr Pediatr; 1977; 34(7 Suppl):CIX-CXX. PubMed ID: 931522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of current practices in management of inherited disorders of amino acid metabolism in Western Europe.
    Wachtel U
    Hum Nutr Appl Nutr; 1986; 40 Suppl 1():61-9. PubMed ID: 3528074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopterin derivatives in normal and phenylketonuric patients after oral loads of L-phenylalanine, L-tyrosine, and L-tryptophan.
    Leeming RJ; Blair JA; Green A; Raine DN
    Arch Dis Child; 1976 Oct; 51(10):771-7. PubMed ID: 1008581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative effects of different inhibitors of phenylalanine hydroxylase and dihydropteridine reductase. In vivo and in vitro study in rats].
    Charpentier C; Domange C; Wolf M; Barthon F; Laggoune B; Lemonnier A
    Arch Fr Pediatr; 1978 Dec; 35(10 Suppl):93-101. PubMed ID: 571268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel aspects of metabolism and function of tetrahydrobiopterin.
    Kaufman S
    J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():492-6. PubMed ID: 1297795
    [No Abstract]   [Full Text] [Related]  

  • 9. Atypical phenylketonuria with normal phenylalanine hydroxylase and dihydropteridine reductase activity in vitro.
    Bartholomé K; Byrd DJ; Kaufman S; Milstien S
    Pediatrics; 1977 May; 59(5):757-61. PubMed ID: 300866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperphenylalaninemia due to dihydropteridine reductase deficiency. Assay of the enzyme in fibroblasts from affected infants, heterozygotes, and in normal amniotic fluid cells.
    Milstien S; Holtzman NA; O'Flynn ME; Thomas GH; Butler IJ; Kaufman S
    J Pediatr; 1976 Nov; 89(5):763-6. PubMed ID: 978323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From the Clinical Conference St. Louis Children's Hospital. Phenylketonuria. Diagnostic and therapeutic dilemma.
    Kahn LI
    Clin Pediatr (Phila); 1970 May; 9(5):263-71. PubMed ID: 5445064
    [No Abstract]   [Full Text] [Related]  

  • 12. Two mutations of dihydropteridine reductase deficiency.
    Ponzone A; Guardamagna O; Ferraris S; Bracco G; Niederwieser A; Cotton RG
    Arch Dis Child; 1988 Feb; 63(2):154-7. PubMed ID: 2894818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diseases of phenylalanine metabolism.
    Parker CE
    West J Med; 1979 Oct; 131(4):285-97. PubMed ID: 388868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylketonuria due to a deficiency of dihydropteridine reductase.
    Kaufman S; Holtzman NA; Milstien S; Butler LJ; Krumholz A
    N Engl J Med; 1975 Oct; 293(16):785-90. PubMed ID: 1160969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings: Atypical phenylketonuria accompanied by a severe progressive neurological illness unresponsive to dietary treatment.
    Smith I; Lloyd J
    Arch Dis Child; 1974 Mar; 49(3):245. PubMed ID: 4856897
    [No Abstract]   [Full Text] [Related]  

  • 16. Variant of dihydropteridine reductase deficiency without hyperphenylalaninaemia: effect of oral phenylalanine loading.
    Blau N; Thöny B; Renneberg A; Penzien JM; Hyland K; Hoffmann GF
    J Inherit Metab Dis; 1999 May; 22(3):216-20. PubMed ID: 10384371
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurotransmitter defects and treatment of disorders of hyperphenylalaninemia.
    Butler IJ; O'Flynn ME; Seifert WE; Howell RR
    J Pediatr; 1981 May; 98(5):729-33. PubMed ID: 6112253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neopterin and biopterin levels in patients with atypical forms of phenylketonuria.
    Nixon JC; Lee CL; Milstien S; Kaufman S; Bartholomé K
    J Neurochem; 1980 Oct; 35(4):898-904. PubMed ID: 7452296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered tetrahydrobiopterin metabolism in patients with phenylalanine hydroxylase deficiency.
    Nardecchia F; Chiarotti F; Carducci C; Santagata S; Valentini G; Angeloni A; Blau N; Leuzzi V
    Eur J Pediatr; 2017 Jul; 176(7):917-924. PubMed ID: 28540433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment with tetrahydrobiopterin in phenylketonuria: treatment strategies and prediction of long-term responders.
    Hennermann JB; Roloff S; Gebauer C; Vetter B; von Arnim-Baas A; Mönch E
    Mol Genet Metab; 2012 Nov; 107(3):294-301. PubMed ID: 23062575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.